PORTLAND, Maine — The Northern New England Chapter of the Cystic Fibrosis Foundation has announced the involvement of Peter Anania in its upcoming Portland Wine Opener.
Sponsors, volunteers and Foundation staff are all excited to be able to celebrate and honor Peter with the Hope Award at the event on November 8 at Ocean Gateway. The goal of The Portland Wine Opener and Peter Anania is to raise $40,000 to support lifesaving cystic fibrosis research, education and care.
Funds raised through The Portland Wine Opener have helped spur dramatic progress in the lives of those who have cystic fibrosis. Fifty years ago, most children with CF did not live long enough to attend elementary school. Today, people with CF are living into their 30s, 40s and beyond.
“We still lose precious young lives to this disease every day. It’s more important than ever that we raise every dollar we can to fight CF,” said Dr. Robert Beall, CEO, CF Foundation. “We’re grateful for every volunteer, donor and corporate sponsor who supports this event.”
Mr. Peter Anania is the Chairman of Anania & Associates Investment Company LLC (AAI), a private investment fund that focuses on manufacturing, service and distribution sectors. Prior to that he was the founding member of Leaders LLC, a mergers and acquisitions firm with offices in Portland and Boston which advises companies around the world.
Mr. Anania serves as a Corporator for Bangor Savings Bank, is an Emeritus Board member of the Maine International Trade Center and is also a charter member of Maine’s District Export Council. He received a BS in Business Administration from the University of Maine at Orono and his MBA from the University of Southern Maine.
“The Foundation’s innovative approach to research has changed the face of this disease for those living with CF,” said Lisa O’Connor, Executive Director of the Northern New England chapter of CF Foundation. “Because of the Portland Wine Opener we have been able to put nearly $30,000 towards research and programs to help support the tremendous progress achieved in fighting this disease.” In fact, the median age of survival for a person with CF has improved from early childhood in the 1950s to 37 years old today.
Cystic fibrosis is a fatal genetic disease that afflicts 30,000 adults and children in the United States and 70,000 people worldwide. It causes debilitating lung infections that lead to premature death. More than 10 million Americans are symptomless carriers of the CF gene.
The CF Foundation is an accredited charity of the Better Business Bureau’s Wise Giving Alliance.
To help fight CF, get involved by calling Northern New England Chapter at 1-800-757-0203 or by visiting http://www.cff.org/Chapters/newengland/.
About the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization, and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The CF Foundation is a donor-supported nonprofit organization. For more information, go to www.cff.org.